a43f31b272
Co-Authored-By: Claude Opus 4.8 <noreply@anthropic.com>
6.3 KiB
6.3 KiB
type, title, description, jurisdiction, legislature, session, identifier, citation, classification, subjects, status, primary_sponsors, version_count, action_count, vote_count, first_action, last_action, source, source_identifier, source_url, source_hash, vintage, source_snapshot, retrieved_at, confidence, tags
| type | title | description | jurisdiction | legislature | session | identifier | citation | classification | subjects | status | primary_sponsors | version_count | action_count | vote_count | first_action | last_action | source | source_identifier | source_url | source_hash | vintage | source_snapshot | retrieved_at | confidence | tags | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bill | Relating to cannabis; to prohibit the sale, distribution, marketing, or possession of psychoactive cannabinoids found in hemp for certain age groups; to levy a five percent tax on the gross proceeds of products containing psychoactive cannabinoids sold at retail; and in connection therewith would have as its purpose or effect the requirement of a new or increased expenditure of local funds within the meaning of Section 111.05 of the Constitution of Alabama of 2022. | Cannabis, sale to minors of psychoactive cannabinoids prohibited; 5% tax on gross proceeds levied | us/states/al | Alabama Legislature | 2023rs | SB 66 | Alabama SB 66 (2023rs) |
|
|
enacted |
|
10 | 28 | 9 | 2023-03-21T04:00:00+00:00 | 2023-05-11T16:30:00+00:00 | openstates | ocd-bill/7e1aedf9-5325-415a-9401-6277a0bb817a | https://alison.legislature.state.al.us/bill-search | bd33e28bab9bee9f73e38439424320687718e0e4a3f9f93361c70d94d15b787e | 2026-07-01 | https://data.openstates.org/daily/2026-07-01/public.pgdump | 2026-07-06 | reported |
|
Alabama SB 66 (2023rs) — Relating to cannabis; to prohibit the sale, distribution, marketing, or possession of psychoactive cannabinoids found in hemp for certain age groups; to levy a five percent tax on the gross proceeds of products containing psychoactive cannabinoids sold at retail; and in connection therewith would have as its purpose or effect the requirement of a new or increased expenditure of local funds within the meaning of Section 111.05 of the Constitution of Alabama of 2022.
Cannabis, sale to minors of psychoactive cannabinoids prohibited; 5% tax on gross proceeds levied
Version chain
The bill's text revisions, in order — the diff chain from filing to enrollment.
- Introduced (filed) — source
- Act 2023-169 (committee substitute) — source
- Amendment 0I8FGC-1 (committee substitute) — source
- Amendment 6LB81Z-1 (committee substitute) — source
- Amendment 9V6VPP-1 (committee substitute) — source
- Amendment F1MMC5-1 (committee substitute) — source
- Amendment N3Y0T8-1 (committee substitute) — source
- Amendment RUR7MN-1 (committee substitute) — source
- Engrossed (committee substitute) — source
- Enrolled (enrolled) — source
Votes
- Roll of the S for Vote 74 on SB66 (2023 Regular Session) — 30–0 (pass) · upper
- Roll of the S for Vote 580 on SB66 (2023 Regular Session) — 32–0 (pass) · upper
- Roll of the S for Vote 75 on SB66 (2023 Regular Session) — 30–0 (pass) · upper
- Roll of the H for Vote 516 on SB66 (2023 Regular Session) — 105–0 (pass) · lower
- Roll of the H for Vote 518 on SB66 (2023 Regular Session) — 105–0 (pass) · lower
- Roll of the S for Vote 73 on SB66 (2023 Regular Session) — 30–0 (pass) · upper
- Roll of the S for Vote 76 on SB66 (2023 Regular Session) — 29–1 (pass) · upper
- Roll of the H for Vote 519 on SB66 (2023 Regular Session) — 105–0 (pass) · lower
- Roll of the H for Vote 517 on SB66 (2023 Regular Session) — 105–0 (pass) · lower
Sponsors
- Tim Melson — primary (person)
Timeline
The legislative action history — every referral, reading, and vote.
- 2023-05-03T04:00:00+00:00 Enrolled
- 2023-05-03T04:00:00+00:00 Concur
- 2023-05-02T04:00:00+00:00 Read a Third Time and Pass as Amended
passage - 2023-05-02T04:00:00+00:00 Adopt
- 2023-05-02T04:00:00+00:00 Adopt
- 2023-05-02T04:00:00+00:00 Adopt
- 2023-05-02T04:00:00+00:00 On Third Reading in Second House
- 2023-04-27T04:00:00+00:00 Read Second Time in Second House
- 2023-04-26T04:00:00+00:00 Reported Out of Committee in Second House
- 2023-04-26T04:00:00+00:00 Reported Favorably (Health)
committee-passage - 2023-04-26T04:00:00+00:00 AMD/SUB (Health)
- 2023-04-12T04:00:00+00:00 Carry Over (Health)
- 2023-04-07T04:00:00+00:00 Referred to Committee (Health)
referral-committee - 2023-04-07T04:00:00+00:00 Read Second Time in Second House
- 2023-04-07T04:00:00+00:00 No Recommendation (Ways and Means General Fund)
- 2023-04-05T04:00:00+00:00 Referred to Committee (Ways and Means General Fund)
referral-committee - 2023-04-05T04:00:00+00:00 Read First Time in Second House
reading-1 - 2023-04-04T04:00:00+00:00 Read A Third Time And Passed As Amended
- 2023-04-04T04:00:00+00:00 Adopt
- 2023-04-04T04:00:00+00:00 Adopt
- 2023-04-04T04:00:00+00:00 Adopt
- 2023-04-04T04:00:00+00:00 On Third Reading in House of Origin
- 2023-03-22T04:00:00+00:00 Read Second Time in House of Origin
- 2023-03-22T04:00:00+00:00 Reported Out of Committee in House of Origin
- 2023-03-22T04:00:00+00:00 Reported Favorably (Healthcare)
committee-passage - 2023-03-21T04:00:00+00:00 Introduced and Referred (Healthcare)
introduction, referral - 2023-03-21T04:00:00+00:00 Read First Time in House of Origin
reading-1 - 2023-05-11T16:30:00+00:00 Enacted as 2023-169
became-law
Source
OpenStates / OpenCivicData bulk snapshot 2026-07-01; origin ocd-bill/7e1aedf9-5325-415a-9401-6277a0bb817a. Confidence: reported (aggregated from official Alabama legislature records).